Association of Low Molecular Weight Plasma Aminothiols with the Severity of Coronavirus Disease 2019.

Evgeny Vladimirovich Kryukov Alexander Vladimirovich IvanovVladimir Olegovich KarpovValery Vasil'evich AlexandrinAlexander Mikhaylovich Dygai Maria Petrovna KruglovaGennady Ivanovich KostiuchenkoSergei Petrovich KazakovAslan Amirkhanovich Kubatiev

Published in: Oxidative medicine and cellular longevity (2021)

Thus, tGSH and rCG can be seen as potential markers for the risk of severe COVID-19. GSH appears to be an important factor to oxidative damage prevention as infection progresses. This suggests the potential clinical efficacy of correcting glutathione metabolism as an adjunct therapy for COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
human health
risk assessment
early onset
drug induced